RECENT NEWS

NHS Blood and Transplant (NHSBT) has opened a state-of-the-art facility which will contribute greatly to the UK’s ability to develop and manufacture new gene and cell therapies.

People across England stand to benefit from a project to identify radical new approaches to prevent cardiovascular disease and reduce pressure on the NHS, following the appointment of Professor John Deanfield as Government Champion for Personalised Prevention.

Women across England will benefit from tailored healthcare and support by new women’s health hubs - improving access and quality of care for services for menstrual problems, contraception, pelvic pain, menopause care and more.

Less than two thirds of staff in the NHS would be happy with the standard of care in their organisation if a friend or relative needed treatment, according to the national NHS staff survey 2022. The proportion who would recommend their organisation as a place to work is also declining, and almost one in three staff “often think about leaving”.

A team from Guy’s and St Thomas’ have become the first in the world to operate through a patient’s mouth using the Versius robotic surgery system.

GPs and pharmacists have helped cut opioid prescriptions in England by 450,000 in under four years, latest data shows, as the NHS unveils a new action plan to crack down on the overuse of potentially-addictive medicines.

Artificial intelligence (AI) that predicts likely missed appointments and offers back-up bookings will be piloted by the NHS in a bid to maximise resources and potentially save billions.

A new Rare Diseases Action Plan for England has been published that will ensure those living with these conditions receive better care and treatment, fairer access to testing and have continued support.

An earlier first birth, a higher number of live births, and starting periods at a younger age are all linked to a higher risk of cardiovascular problems in women, according to new research.

In a new report, the Public Accounts Committee has warned that cancer waiting times are at their worst recorded level and NHS England will not meet its first cancer recovery target.

Applications for innovative proposals to harness canSERV's unified oncology services are now being invited. A first of its kind, the largest European-wide consortium of research infrastructures is offering free-of-charge transnational access to cutting-edge services to develop breakthrough personalised cancer treatments.

Althea UK and Medipass Healthcare – two of the UK’s leading Managed Equipment Services (MES) companies – have announced they have merged operations and have been rebranded as Ergéa.

Researchers at Chalmers University of Technology in Sweden have developed a method for predicting fall accidents and cognitive illnesses such as Alzheimer’s disease by reading a person’s walking pattern with the aid of a radar sensor. The small sensor can be attached to furniture, walls and ceilings, both in the home and in a healthcare setting.

The numbers are now in and Arab Health 2023 has made history by being the most visited edition with 135,880 professionals visits from 183 countries and 3,358 exhibitors.

A review into the progress made on recommendations made in the 2019 Topol Review has been released by Health Education England.

Vanguard Healthcare Solutions, a leading provider of flexible clinical infrastructure, is hosting an information event for healthcare professionals which will offer a tour of one of its new mobile operating theatres.

With NHS England waiting lists hitting a record 7.2m, it could be time to ‘be brave’ and ‘take a blank sheet of paper’ to design new patient care pathways. This was among several key points raised by health professionals as they discussed how elective care pressures can be alleviated through community MSK services, at Connect Health’s latest Change event.

A £300 million contract has been awarded to Bouygues UK to build Oriel, a new eye care, research and education centre in Camden.

Abbott has released the latest installment in the company’s multi-year Beyond Intervention series of global healthcare market research designed to uncover challenges that arise within the patient journey of people living with cardiovascular disease and to identify opportunities for patient care improvement.

Founders of University of Edinburgh-supported start-ups, including many that are seeking growth investment, will be given the opportunity to showcase their companies to an audience of investors, business support groups, and fellow entrepreneurs at two key events taking place next month.